Obefazimod

N/A

Report date: 2026/04/27 20:02:09
NME

Base Information

Drug NameObefazimod
Drug Alias NameABX-464SPL-464
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionReverse transcriptase inhibitorsMicroRNA-124 inducers
TargetsReverse transcriptaseMicroRNA-124
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Crohn DiseaseColitis, Ulcerative +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[38] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAbivax Sa
China Registration ClassN/A

Develop Information

Active CompaniesAbivax SaIqvia Rds (Shanghai) Co LtdDelpharm Lille Sas
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseColitis, UlcerativeColitis +[4] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)HIV Infections

Other Information

ATC CodeN/A
Related LinksN/A